Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Black Diamond Therapeutics Inc (BDTX)

Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 137,502
  • Shares Outstanding, K 56,585
  • Annual Sales, $ 0 K
  • Annual Income, $ -82,440 K
  • EBIT $ -81 M
  • EBITDA $ -81 M
  • 60-Month Beta 2.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.41

Options Overview Details

View History
  • Implied Volatility 109.31% ( -0.68%)
  • Historical Volatility 67.93%
  • IV Percentile 28%
  • IV Rank 28.84%
  • IV High 331.36% on 03/25/24
  • IV Low 19.30% on 11/29/23
  • Put/Call Vol Ratio 0.06
  • Today's Volume 52
  • Volume Avg (30-Day) 133
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 4,537
  • Open Int (30-Day) 5,116

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.31
  • Number of Estimates 7
  • High Estimate -0.25
  • Low Estimate -0.36
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +8.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.31 +9.96%
on 11/21/24
3.44 -26.16%
on 11/12/24
-0.77 (-23.26%)
since 10/22/24
3-Month
2.31 +9.96%
on 11/21/24
6.66 -61.86%
on 08/23/24
-3.58 (-58.50%)
since 08/22/24
52-Week
2.15 +17.87%
on 11/27/23
7.66 -66.84%
on 05/06/24
+0.20 (+8.55%)
since 11/22/23

Most Recent Stories

More News
Black Diamond: Q3 Earnings Snapshot

Black Diamond: Q3 Earnings Snapshot

BDTX : 2.54 (+4.53%)
Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

BDTX : 2.54 (+4.53%)
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

BDTX : 2.54 (+4.53%)
Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway

BDTX : 2.54 (+4.53%)
Black Diamond: Q2 Earnings Snapshot

Black Diamond: Q2 Earnings Snapshot

BDTX : 2.54 (+4.53%)
Black Diamond: Q1 Earnings Snapshot

Black Diamond: Q1 Earnings Snapshot

BDTX : 2.54 (+4.53%)
Black Diamond: Q4 Earnings Snapshot

Black Diamond: Q4 Earnings Snapshot

BDTX : 2.54 (+4.53%)
Black Diamond: Q3 Earnings Snapshot

Black Diamond: Q3 Earnings Snapshot

BDTX : 2.54 (+4.53%)
Black Diamond: Q2 Earnings Snapshot

Black Diamond: Q2 Earnings Snapshot

BDTX : 2.54 (+4.53%)
Stocks Set to Open Lower as Investors Await U.S. Inflation Data and Big Bank Earnings, Chinese Inflation Data Disappoints

September S&P 500 futures (ESU23) are down -0.04%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.05% this morning as weak inflation data from China added to a gloomy global economic outlook...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
LEVI : 16.32 (+2.19%)
COST : 964.01 (+0.87%)
ZION : 60.58 (+2.43%)
CMA : 71.09 (+3.18%)
JPM : 248.55 (+1.55%)
WFC : 75.96 (+1.51%)
C : 69.84 (+1.29%)
BAYN.D.DX : 19.830 (+1.67%)
BDTX : 2.54 (+4.53%)
SCHW : 81.26 (+0.57%)

Business Summary

Black Diamond Therapeutics Inc. is an oncology medicine company. It engages in discovery and development of small molecule, tumor-agnostic therapies. The company's lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor...

See More

Key Turning Points

3rd Resistance Point 2.85
2nd Resistance Point 2.73
1st Resistance Point 2.64
Last Price 2.54
1st Support Level 2.42
2nd Support Level 2.30
3rd Support Level 2.21

See More

52-Week High 7.66
Fibonacci 61.8% 5.56
Fibonacci 50% 4.91
Fibonacci 38.2% 4.26
Last Price 2.54
52-Week Low 2.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar